01 Oct 2017
Home
File List, RICO
1988 Steere says Lyme is like a B cell leukemia
Assoc Blogs-n-Webs:
TruthCures.org
badlymeattitude.com/
immune2lies.com/
researchfraud.com/
may12.org
meadvocacy.org/
truthbetoldx81
lymecryme
CrymeDiseaseNorway
crymedisease
theothersideofthestretcher
rjspiritualityandtuth
LymeTruthSite
JC-LilnkedIn
KD-Linkedin.com
LD-LinkedIn
JC-academia.edu
KD-academia.edu
CDC "SPIDER"
Fungal Exosomes Inhibit Apoptosis
IDSA:
"Vaccines serve the mfgs, not their victims"
RICO_filed_USDOJ
BlumenthalAntiTrust Lawsuit
Exosomes, Blebs
Spirochetal_Dementia
PDFs
CDC Admits Fraud, 2016
Dattwyler, 1988
Golightly, 1988
Dressler,
1994
BarbourFish, 1993
Dearborn,
1994
BarbourFishpdf.pdf
Pathogenic Fungi
Bush's warcrimes, Oct 2000
Trainer
170708 |
| |
RICO CONSPIRACY DOCUMENTS - COMMERCIALIZED ACCIDENTAL RELEASE
BACKGROUND; COMMERCIALIZED ACCIDENTAL RELEASE
According to an employee of Porton Down (presumably Susan O'Connell) when confronted by a member of the UK House of Lords over whether or not Porton Down and the CDC were still working with Borrelia as a bioweapon, the employee at first tried to deny that they were experimenting with Borrelia as a bioweapon (see what happened in Korea and China during the Korean War). The UK Lord said, 'nonsense, don't lie to me about that,' essentially, and again asked the Porton Down employee if they were still studying Lyme as a bioweapon. The Porton Down employee then admitted that the accidental release "was given over to industry." Soon thereafter, Susan O'Connell either quit or was fired by the UK NHS (end of March, 2012).
We knew this anyway, and all along said, "We do not care if Lyme was an accidental release, but we do not need to be the victims of the RETards who handled it afterwards, who clearly did not know the first thing about Borrelia, relapsing fever and especially its surface antigens, as revealed by Crazy Eddie McSweegan in his 1986 letter to Senator Goldwater, when he speaks about 'cloned ehrlichial ligands' which is code language for Lyme vaccines. These special Eddies did not know enough basic science to even see if other vaccines of the same type had been tried before and what the outcome was (Tuberculosis TLR2-agonist failed vaccines)."
You will see in the following documents and on
120702.htm
both the bioweapons evidence and the RETARDED scientists (Susan O'Connell's "industry") who conspired to sell a vaccine that they knew did not prevent Lyme and for the basic capital investment (royalties and a monopoly on the national blood to pharm patentable goodies from all our blood, not just vector borne diseases data, but genetic bioweapons susceptibility data) for their stated enterprise, the ALDF.com
This is a snippet of an advertisement that was on Corixa.com's website where we see Corixa/Yale/Imugen being awarded an NIH biodefense contract for lying about the outcome of LYMErix. Corixa was later purchased by SmithKline, so all that 11.5 million dollars worth of USA biodefense data is now owned by a foreign company: 
http://www.actionlyme.org/CORIXA_NIH_BIODEFENCE.pdf
More about this at the bottom of this page. Scroll down for a lot more...
REPORTS YOU WILL NEED TO SHOW CONSPIRACY TO DEFRAUD Americans, Dumb Europeans, Russia, the Chinese...
Go to MedLine and enter borrelia and host-adapted:
http://www.ncbi.nlm.nih.gov/pubmed?term=%28%22borrelia%22%5BMeSH%20Terms%5D%20OR%20%22borrelia%22%5BAll%20Fields%5D%29%20AND%20host-adapted%5BAll%20Fields%5D&cmd=DetailsSearch
Those are all the people who know Lyme is simply a Relapsing Fever organism, that vaccines won't work, and that the Dearborn case definition is research fraud.
Host-adapted means the spirochete won't be expressing the same antigens it did when it was fresh out of a tick, due to antigenic variation.
DEARBORN AND EARLIER
Steere's original 1986
Lyme-diagnostic serology
report: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC423723/?tool=pubmed
The above was mentioned at the 2001,
Jan, FDA Meeting on LYMErix Adverse
Events by Kathleen Dickson: http://www.fda.gov/ohrms/dockets/ac/01/slides/3680s2.htm
1990 CDC Serology standard (same as
Steere's 1986 report; means Lyme is
Relapsing Fever): http://www.actionlyme.org/CDC_STANDARD_1990.htm
Dearborn Invitations (connotes
consensus, which it was not): http://www.actionlyme.org/DEARBORNINVITATIONS.pdf
Dearborn booklet (111 pages) showing no one agreed
with Steere's proposal and who was on
all the committees http://www.actionlyme.org/DEARBORN_PDF.pdf
Gary Wormser's peer-reviewed assessment
of Steere's Dearborn proposal where he
says only 9/59 patients met the Steere/Dearborn
criteria for IgG (85% of cases are
missed):
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=266355&blobtype=pdf
"Steere in Europe" (the other report
missing from Dearborn booklet which
shows the research fraud where OspA and
B are left out http://www.actionlyme.org/STEERE_IN_EUROPE.htm
(look at the ELISA cutoffs, this is
clearly fraud)
“The group 1 strain of B. burgdorferi, G39/40, used in this study and
in the previous study of US patients was isolated from an Ixodes
damini tick in Guilford, Connecticut [21]. The group 2 strain, FRG
[Federal Republic of Germany], was isolated from Ixodes ricinus near
Cologne [22]. The group 3 strain, IP3, was isolated from Ixodes
persulcatus near Leningrad [23]. All three strains used in this study
were high passage isolates, which were classified by Richard Marconi
(Rocky Mountain Laboratory, Hamilton, MT) using 16S ribosomal RNA
sequence [revealing that he knows the OspA gene is the shell
game] determination as described [11, 24]. The recombinant
preparations of OspA and OspB used in this study were purified maltose-
binding protein-Osp fusion proteins derived from group 1 strain B31 [25]. The fusion proteins contained the full-length
OspA or OspB
sequence without the lipid moiety or the signal sequence -"
[OspA and B (encoded on the same
plasmid) will not be seen in
antibody-response without the lipids
attached to the Osps. This was how
OspA and B were left out of the Dearborn
panel - pure research fraud.]
CDC staff (Barbara Johnson) patents (5 of them) from 1992
in Europe with SmithKline explaining
that there are 2 kinds of Lyme, the
HLA-linked and the non-HLA linked,
meaning the same characters who were
there at the Dearborn conference, knew
the outcome was scientific fraud and
that it served their own patent
interests for Lyme to be the fake
disease it is now (high antibody
concentration). There can be no
vaccines or antibody tests other than
flagellin for Relapsing Fever http://www.wikipatents.com/CA-Patent-2135800/compositions-useful-in-diagnosis-and-prophylaxis-of-lyme-disease
CDC's (Barbara
Johnson) final serology standard (No OspA
and B, which are encoded on the same
plasmid) http://wonder.cdc.gov/wonder/prevguid/m0038469/m0038469.asp
CDC's Barbara Johnson was present at
Dearborn and approved a standard she
knew was false and she did so to suit
her own "patents in Europe with
SmithKline" bottom line: http://www.actionlyme.org/Dearborn_Who_Approved.htm http://www.actionlyme.org/CDCS_PARTICIPATION_IN_LYME_CRIMES.htm
CDC Crooks say in their 5
European patents with SmithKline: "Certain of these antigens are characterized as being B. burgdorferi B31 strain
specific and major histocompatibility complex (MHC) nonrestricted
[these would be all the cases that are not
"Bad-Knees-Only']. Certain other
of these antigens are characterized as being MHC restricted
[these would be all the cases of
Dearborn-Positive-Bad-Knees-Only]...."
CONCLUSION : Lyme used to be considered Relapsing Fever and this was independently observed by Allen Steere, who said in 1986 that one only needed band 41 (flagellin) to be diagnosed with Lyme. The CDC then sent Steere on a junket to Europe to narrow the disease definition the same year CDC staff (the other CDC officers - not Steere because he's not too bright) claimed patents with SmithKline in the European patent database. Those patents identify two kinds of Lyme: Steere's HLA-linked "bad-knees" and the other, Great Imitator, seronegative outcomes. We find that fungal antigens carried by borrelia - like OspA - are themselves responsible for the Great Imitator outcomes in that they appear to inhibit apoptosis in EBV-infected cells, and tolerize to fungal infections in the blood, which contribute to fatigue. Paralyzing fatigue is characteristic of late, chronic, neurologic Lyme.
WHO DID WHAT ONCE OspA and B WERE
DROPPED FROM THE STANDARD
Persing and Schoen's RICO strain (dropped
OspA and B, but was determined to be
burgdorferi via the
DNA/RNS
shell game) report:
http://jcm.asm.org/cgi/reprint/35/1/233?view=long&pmid=8968914
Persing and Schoen's RICO strain and monopoly
patent on post-LYMErix blood patent: http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6045804.PN.&OS=PN/6045804&RS=PN/6045804 "Additional uncertainty may arise if the
vaccines are not completely protective;
vaccinated patients with multisystem
complaints characteristic of later
presentations of Lyme disease may be
difficult to distinguish from patients
with vaccine failure....
"The present invention provides a method
useful to detect a B. burgdorferi
infection in a subject. The method
provided by the invention is
particularly useful to discriminate B.
burgdorferi infection from OspA
vaccination, although it is sufficiently
sensitive and specific to use in any
general Lyme disease screening or
diagnostic application. Thus, the
method of the invention is particularly
appropriate for large scale screening
[THE
MONOPOLY- this has implications for the
current situation where this cabal now
contracted with the Red Cross for a
do-over of the same fraud-monopoly
crime; they are interested only in
patentable goodies in the blood while
lying about everything else]
or diagnostic applications where only
part of the subject population has been
vaccinated or where the vaccination
status of the population is unknown. "
Evidence that Corixa, Imugen and L2
Diagnostics were officially SEC
"partners" https://groups.google.com/forum/?hl=en&fromgroups#!topic/sci.med.diseases.lyme/D6v-QHQdMbc
Evidence that Corixa did the advertising
for the Corix-Imugen-L2 Diagnostics
("partners") cabal https://groups.google.com/forum/?hl=en&fromgroups#!topic/sci.med.diseases.lyme/cy9beTF_Uqs
Evidence that the Yale Endowment Fund
funded the former Yale Lyme and Lupus
clinic, "L2 Diagnostics" http://www.actionlyme.org/LYME_CORRUPTICUT.htm
Proof that Corixa's newest model of
adjuvant was NOT
tri-lipidated. Persing's company,
Corixa, advertising selling a new form
of OspA-adjuvant, monophosphoryl A,
which is meant to be a mono-acyl version
of OspA-the adjuvant, but not so toxic
as OspA. http://www.actionlyme.org/EMBASSIES_CORIXA_TLR_13_JULY_06.htm
CONCLUSION: We speculate that Steere is involved with Imugen financially, and his payoff for putting his name on the Dressler/Steere falsified serology reports was an official partnership with Corixa and Steere's pal Robert Schoen at L2-Diagnostics, Yale's former Lyme and Lupus Clinic. Corixa, Imugen and L2 Diagnostics intended a monopoly on all blood in the United States because in it would be new vector-borne diseases' DNA to patent, and it also holds bioweapons value (HLA-differences among peoples) as you can see from the activities of the Russian scientists who publish in association with the ALDF.com cabal at New York Medical College, Valhalla, NY: http://www.actionlyme.org/BOGUS_RUSSIAN_NYMC_ARTICLES.htm
THE SCIENTIFICALLY VALID
ANTIBODY TEST FOR RELAPSING FEVER
Fikrig and Flavell's scientifically
valid antibody test for B burgdorferi
Relapsing Fever: http://iai.asm.org/content/59/10/3531.full.pdf+html?view=long&pmid=1894359
Fikrig and Flavell's scientifically
valid antibody test patent (5,618,533) http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=5618533.PN.&OS=PN/5618533&RS=PN/5618533
Fikrig and Flavell's LYMErix OspA
patent http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=5747294.PN.&OS=PN/5747294&RS=PN/5747294
See the PowerPoint Presentation
here to see where Yale and the CT Dept
of Agriculture spiked the Borrelia mix with extra flagellin to
detect cases of Lyme where the antibody
concentration is LOW - one of the goals and attributes of a scientifically valid
method (FDA rules): http://www.actionlyme.org/CRYMEDISEASE_CHP1.htm
The species determinant =
Flagellin, See the Taxonomy database: http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=138&lvl=3&lin=f&keep=1&srchmode=1&unlock
Dattwyler talking about the incurability of Spirochetal Diseases in 1988:

http://www.actionlyme.org/DODD_KENNEDY.htm (know what goes on on Plum Island)
YALE AND ALAN BARBOUR SAY THERE
CAN BE NO Osp-BASED VACCINES AGAINST
RELAPSING FEVER
Fikrig and Flavell's report where
they show LYMErix would not work because
Lyme is Relapsing Fever ("selection
pressure") http://www.actionlyme.org/SELECTION_PRESSURE_NO_VACCINE_POSSIBLE.htm http://www.ncbi.nlm.nih.gov/pmc/articles/PMC173206/pdf/631658.pdf|
Alan Barbour in 1992 reported that OspA,
too, undergoes antigenic variation and
therefore could not have been a vaccine http://www.actionlyme.org/BARBOUR_MUTANTS_1992.htm
Alan Barbour discussing antigenic
variation in general and what that means
re diagnostics and vaccines (can't): http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627965/?tool=pubmed
Andrew Pachner (formerly at Yale) Discussing...:
http://www.actionlyme.org/PACHNER_BRAINS_1990.htm
"The plasmid content of N40Br was
different from that of the infecting
strain implying either a highly
selective
process during infection or
DNA rearrangement in the organism in
vivo. "
Discussing antigenic variation; meaning, you can't Western Blot someone with late Lyme with a tick fresh out of a tick, due to antigenic variation or what the crooks call host-adaptation. This means Dearborn is moot, and especially Klempner.
CONCLUSION:
Fikrig and Flavell own the patents to Fla-burgdorferi and LYMErix OspA, and Barbour owns the patent for the ImmuLyme OspA vaccine, yet here they are saying the very idea is nonsense. Neither advised to stop the vaccine trials which were underway by 1993. Lyme is Relapsing Fever.
THE YALE, CORIXA, IMUGEN CABAL
KNEW LYMErix (OspA) CAUSED A CHRONIC-LYME-LIKE
ILLNESS
Yale's Robert Schoen says in 1998 not to test LYMErix victims and minimizes their symptoms knowing chronic Lyme is identical to what Schoen says is "nonspecific" because the exact reverse statement is in the Corixa-RICO patent "multisystem complaints characteristic of late Lyme", This is that textbook:
http://www.amazon.com/Lyme-Disease-Key-Diseases-Series/dp/0943126584/ref=sr_1_fkmr0_2?ie=UTF8&qid=1341914626&sr=8-2-fkmr0&keywords=lyme+disease+rhan+and+evans
http://www.actionlyme.org/SCHOEN_INSTRUCTING_DOCS_TO_BLOW_OFF_LYMERIX_INJUREES.htm


Dave Persing discussing why you should
not use the native or original Osps as
vaccines (and Robert Schoen would know
this too): http://www.actionlyme.org/STEALTH_DISABLERS.htm
"Accordingly, the methods of the
invention provide a powerful and
selective approach for modulating the
innate immune response pathways in
animals without giving rise to the toxicities often associated with the
native bacterial components that
normally stimulate those pathways."
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=/netahtml/PTO/srchnum.htm&r=1&f=G&l=50&s1=6,800,613.PN.&OS=PN/6,800,613&RS=PN/6,800,613 http://www.actionlyme.org/EMBASSIES_CORIXA_TLR_13_JULY_06.htm
Persing and Schoen's RICO strain and monopoly
on post-LYMErix blood patent http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6045804.PN.&OS=PN/6045804&RS=PN/6045804 "Additional uncertainty may arise if the
vaccines are not completely protective;
vaccinated patients with multisystem
complaints characteristic of later
presentations of Lyme disease may be
difficult to distinguish from patients
with vaccine failure....
SmithKline bought Corixa to keep all
that OspA-failure-and-harm data proprietary
Munchausen's accusations against people
they clearly knew were sick (1998) in this book:
http://www.amazon.com/Lyme-Disease-Key-Diseases-Series/dp/0943126584/ref=sr_1_fkmr0_2?ie=UTF8&qid=1341914626&sr=8-2-fkmr0&keywords=lyme+disease+rhan+and+evans
http://www.actionlyme.org/MUNCHAUSENS.htm
http://www.alibris.com/search/books/qwork/4078360/used/Lyme%20Disease This is the book the following is published in:
On the previous page of this
Munchausen's book:

Steere says "seronegative Lyme is a conflict in terms when talking about arthritis" meaning that since the Dearborn conference, "Lyme Disease" officially became the arthritis, only (in the Munchausen's/Schoen lies book here>>
http://www.amazon.com/Lyme-Disease-Key-Diseases-Series/dp/0943126584/ref=sr_1_fkmr0_2?ie=UTF8&qid=1341914626&sr=8-2-fkmr0&keywords=lyme+disease+rhan+and+evans

Seronegative Lyme disease is a subtle, attenuated illness. He means "low antibody concentration" - see the Western Blots
in the RICO complaint to see the difference: http://www.actionlyme.org/USDOJ_COMPLAINT_RICO.htm
IDSA Reviews, Special Supplement on
Spirochetal Diseases (you have to look at all of them) http://www.actionlyme.org/CHP_9_IDSA_REVIEWS.htm
Paul Duray twice reports that chronic
Lyme victims have mutated B cells (1989,
1992 = Schutzer's book) http://www.actionlyme.org/IDSA_CLINIPATH_DURAY.htm http://www.actionlyme.org/Duray.htm
Dattwyler and Luft report that one has
to look for new IgM bands (the old
standard) in order to diagnose Lyme (1992, Schutzer's book)
Trinity Biotech bought MarDx (Jeremy Gray is in
Dublin; Gray is criminal partners with
Susan O'Connell at Porton Down/ UK's NHS) to keep all the OspA
vaccines trial data (unreadable blots)
out of the United States.
Dave Persing and Lenny Sigal report that
the Western Blots of OspA vaccinated
people assessed with MarDx were
unreadable (blot smudging is due to the
fact that the OspA molecules were not
micellized enough by the carrier; people
were injected with blobs of various
sized lipids, resulting in all the
strokes associated with the Phase III
vaccine trial
http://www.journals.uchicago.edu/doi/pdf/10.1086/313920
Robert Schoen reports in the Phase VI
LYMErix trial that tons of people died
or were made sick or got cancer (OspA
helps activate Epstein-Barr), and this
would be because OspA sticks to itself,
as also reported by the Koreans when
they reported that the HIV gp120 antigen
is the same thing as LYMErix (triacyl
lipopeptide). http://www.actionlyme.org/OspA_IV.htm Korean Pam3Cys = HIVgp120
PDF
These are the essentials
to demonstrate fraud over the testing
and that the intention of it was to
falsify the vaccines outcomes and
changed the definition of the disease to
"arthritis" or hypersensitivity, alone,
and as shown in the RICO complaint to
the USDOJ
http://www.actionlyme.org/USDOJ_COMPLAINT_RICO.htm
Look at the blots in the RICO complaint.
This crime is so obvious....
TRAINING PROTOCOL:
◄THE IDSA CRAZY-WHEEL (A Brief History, from 1986 to 2011,
where Cliff Harding reports on the mechanism of Steere's Dearborn
"Only-Bad-Knees-Disease." And Allen Steere doesn't. Ever.)
See the letter to Senator Goldwater in 1986 by Crazy Eddie that started it
all:
http://www.actionlyme.org/GOLDWATER_LETTER.htm And the US Navy's FURIOUS
reply to McSweegan's accusations. See also that he speaks about "cloned
ehrlichial ligands" which is code-language for Lyme vaccines. McSweegan is
such an incompetent scientist, that he does not know the mechanism by which
Relapsing Fever is called Relapsing Fever (antigenic variation), nor that
Ehrlichia do the exact same thing.
Scientific Validity Powerpoint
http://www.actionlyme.org/SV_PPT_2.htm
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm122858.pdf
TERMINOLOGY:
http://www.youtube.com/playlist?list=PL7A9646BC5110CF64&feature=plcp
Kahn Academy B Cells
http://www.youtube.com/watch?v=Z36dUduOk1Y&feature=relmfu
Kahn Academy Overview of Adaptive and Innate Immunity
http://www.youtube.com/watch?v=rp7T4IItbtM&feature=relmfu
Review of Dearborn
http://www.actionlyme.org/DEARBORNINVITATION.pdf
http://www.actionlyme.org/DEARBORN_PDF.pdf
EXACTLY how Steere falsified the test (no-OspA-B)
http://www.actionlyme.org/STEERE_IN_EUROPE.htm
The Corixa-Yale RICO and the CDC's Patents
http://www.actionlyme.org/RICO_CONSPIRACY_DOCUMENTS.htm
(PROOF that Corixa-Yale knew OspA caused systemic illness: 1) Schoen in the
"Munchausen's" book discussing chronic Lyme, but blaming the victim, 2,3) the
two
Corixa patents, 4) the Corixa ad where they sell a new adjuvant product that is
not
a TLR2-agonist > bottom of this page)
1)
http://www.actionlyme.org/SCHOEN_INSTRUCTING_DOCS_TO_BLOW_OFF_LYMERIX_INJUREES.htm
2)
"Accordingly, the methods of the
invention provide a powerful and
selective approach for modulating the
innate immune response pathways in
animals without giving rise to the
toxicities often associated with the
native bacterial components that
normally stimulate those pathways."
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=/netahtml/PTO/srchnum.htm&r=1&f=G&l=50&s1=6,800,613.PN.&OS=PN/6,800,613&RS=PN/6,800,613
3)
"Additional uncertainty may arise if the
vaccines are not completely protective;
vaccinated patients with multisystem
complaints characteristic of later
presentations of Lyme disease
may be
difficult to distinguish from patients
with vaccine failure....
http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6045804.PN.&OS=PN/6045804&RS=PN/6045804
4)
http://www.actionlyme.org/CORIXA_NIH_BIODEFENCE.pdf
Lyme is Relapsing Fever (Taxonomy Database, Basic Genetics)
http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=138
Yale's Valid Antibody testing
http://www.actionlyme.org/CRYMEDISEASE_CHP1.htm
Barbour and NIAID say band 41 - generic - is valid to diagnose all Borreliae
(H9724)
A Borrelia-specific monoclonal antibody binds to a flagellar epitope.
CONCLUSION: Lyme is Relapsing Fever; they falsified the test so that
only the HLA-linked hypersensitivity response is allowed to be a "case;" they
knew all along how to diagnose Lyme or any Relapsing Fever organism via
flagellin antibody; Schoen, Persing, Steere and Molloy (Imugen) knew all along
that LYMErix vaccination produced a chronic-Lyme-like illness but they trashed
LYMErix victims the same way they trashed Chronic Lyme (formerly called
Relapsing Fever, the name implying chronicity) victims.
=======================
The History of Relapsing Fever
http://www.actionlyme.org/RICOCHRON.htm

http://ijs.sgmjournals.org/content/46/4/898.long
Plum Island and Durland Fish:
http://www.actionlyme.org/PIIB.htm

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC228430/pdf/332427.pdf
IDSA reports that Lyme is incurable with about 20 articles of their own:
http://www.actionlyme.org/BRAIN_PERMANENT.htm
Patents and Alan Barbour
http://www.actionlyme.org/CENTRAL_LYME_RICO_PATENTS.htm and flagella-less
borrelia patent and statements about antigenic variation in OspA and in other
VBDs (meaning vaccines and test kits are useless)
Scientifically Valid Biomarkers Discovered by the Crooks and Mark Klempner
http://www.actionlyme.org/BIOMARKERS.htm
http://www.actionlyme.org/MKLEMPNER.htm ; Klempner does not use the valid
biomarkers- including one of his own, MMP-130, to assess the standard of care
(and not retreatment) 4.7 million dollar study which is the basis of the
"guidelines." This is research fraud of the psychiatric "check-list" type.
CDC reports that Borreliae are intracellular
http://www.ncbi.nlm.nih.gov/pubmed/17045505
Klempner reports that Borreliae are intracellular
http://www.actionlyme.org/MarkKlempner_Fibroblasts.htm
CONCLUSION: Klempner article is research fraud and can be thrown out.
They all proved Relapsing Fever is a permanent infection, and
intracellular. The "guidelines," based on Klempner, were merely an attempt
to reinforce the notion that the Dearborn diagnostic standard was real and
valid.
=======================
Blumenthal AntiTrust Subpoenaed all IDSA's Self-Incriminating
documents, but for a year and half,
the crooks refused; those
documents were:
IDSA Reviews
http://www.actionlyme.org/CHP_9_IDSA_REVIEWS.htm
IDSA's Other Patent Claims
http://www.actionlyme.org/CENTRAL_LYME_RICO_PATENTS.htm
IDSA's Treatment Failure Data
http://www.actionlyme.org/IDSA_TMTFAILS.htm
http://www.actionlyme.org/BRAIN_PERMANENT.htm (about 20 reports, total)
Evidence that the crooks are playing a DNA/RNA shell game:
http://www.actionlyme.org/PRIMERSHELLGAME.htm
Dattwyler and Steere discuss seronegative Lyme (NK Cell Suppression)
http://www.actionlyme.org/DATTWYLER_NK_SUPPRESSION.htm
http://www.actionlyme.org/STEERES_SERONEG_LYME_ASSAY.htm
Paul Duray publishing for IDSA (EBV and cancerous B cells)
http://www.actionlyme.org/Duray.htm
http://www.actionlyme.org/IDSA_CLINIPATH_DURAY.htm
[Evidence for Mouse Gammaherpesvirus being transmitted by ticks:
http://www.ncbi.nlm.nih.gov/pubmed?term=21732020 ]
Gary Wormser's peer reviewed article about how Dearborn detected 15% of the
cases
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=266355&blobtype=pdf
Gary Wormser's peer-reviewed article about how OspA was immunosuppressive
http://www.ncbi.nlm.nih.gov/pubmed/10865170
UConn's Justin Radolf and Clifford Harding discover that OspA is Pam3Cys and
causes A) immunosuppression and B) Steere's HLA-linked hypersensitivity response
(see also Dave Dorward)
http://www.actionlyme.org/101016/htm
==========================
Plum Island and Bioweapons data:
http://www.actionlyme.org/PIIB.htm
and
http://www.actionlyme.org/120702.htm (Congressional Record re what would be
the characteristics of a bioweapon - delayed response, stealth, no antibodies &
"overwhelm" the immune system; that happens to be exactly what OspA does.)
CDC writes "bogus articles"
http://www.actionlyme.org/120305_CDC_BOGUSARTICLES.htm
Durland Fish writes "bogus articles"
http://www.actionlyme.org/TICK_BITE_CONSPIRACY.htm
Russians at NYMC write bogus articles about intracellular spirochetes and the
spheroplast form, while being interested in the HLA-haplotypes of peoples from
all sorts of nations (this is bioweaponeering and disease-spin to hide what
really is a bioweapon/stealth disabler)
http://www.actionlyme.org/BOGUS_RUSSIAN_NYMC_ARTICLES.htm
McSweegan reveals he stalked and harassed me, Karen, and Janice Beers
http://www.actionlyme.org/SWEEG_WATCH.html
http://www.actionlyme.org/McSweegan_Relentless.htm
McSweegan discusses his trip to an Israeli Bioweapons Plant
http://groups.google.com/group/scilyme2/browse_thread/thread/97145b659573ba9d/91f61251f09c793f?hl=en&lnk=gst&q=double-oh#91f61251f09c793f
John Dunn at Brookhaven and the discussion of Lyme, stealth disablers and MS all
in the same paragraph.
http://www.actionlyme.org/JohnDunn_Brookhaven.htm
Evidence for OspA/Lyme and EBV inhibiting apoptosis (potential synergy)
http://www.actionlyme.org/101016.htm
What we know about what goes on on Plum Island:
http://www.actionlyme.org/PIIB.htm
(mycoplasma)
Gary Wormser's peer-reviewed article about how OspA was immunosuppressive
http://www.ncbi.nlm.nih.gov/pubmed/10865170
Dattwyler and Steere discuss seronegative Lyme (NK Cell Activity Suppression)
http://www.actionlyme.org/DATTWYLER_NK_SUPPRESSION.htm
http://www.actionlyme.org/STEERES_SERONEG_LYME_ASSAY.htm
Evidence for Mouse Gammaherpesvirus being transmitted by ticks:
http://www.ncbi.nlm.nih.gov/pubmed?term=21732020
Lyme/LYMErix
Cryme Reveals New Paradigm in Health/Disease:
"Bacterial/Viral Coinfections";
TLR2 (fungi)Signaling Depletes IRAK1 and Inhibits Induction of Type 1 by TLR7/9
(viruses)-- -CV
Harding, 2012
CORIXA'S ADVERTISEMENT FOR A NEW FORM OF OSP-A AS
AN ADJUVANT
that is not a TLR-2 Agonist because they knew LYMErix did not work and
was toxic


|